Active Stocks to Watch: Puma Biotechnology (NYSE:PBYI), Merck & Co. Inc. (NYSE:MRK), Heritage-Crystal Clean, Inc (NASDAQ:HCCI), Advent Software (NASDAQ:ADVS)

On Monday shares of Puma Biotechnology, Inc. (NYSE:PBYI) closed at $200.98. Puma Biotechnology, Inc. (NYSE:PBYI), announced financial results for the first quarter ended March 31, 2015. Based on accounting principles generally accepted in the United States (GAAP), Puma reported a net loss applicable to common stock of $52.5 million, or $1.66 per share, for the first quarter of 2015, compared to a net loss of $19.8 million, or $0.67 per share, for the first quarter of 2014.

Merck & Co. Inc. (NYSE:MRK) in last trading activity decreased -1.22% to close at $60.00. Company weekly performance is -1.06% while its quarterly performance stands at 3.70%. Merck & Co. Inc. (NYSE:MRK) is -4.93% away from its 52 week high. Merck & Co. (NYSE:MRK)‘s stock had its “buy” rating reissued by stock analysts at Bank of America in a report issued on May 04. They currently have a $65.00 price objective on the stock.

On last trading day Heritage-Crystal Clean, Inc (NASDAQ:HCCI) advanced 1.91% to close at $12.83. Its volatility for the week is 5.38% while volatility for the month is 4.14%. HCCI’s sales growth for past 5 years was 28.10% and its EPS growth for past 5 years was -33.50%. Heritage-Crystal Clean, Inc (NASDAQ:HCCI) monthly performance is -4.82%. Heritage-Crystal Clean (NASDAQ:HCCI) saw its loss narrow to $0.94 million, or $0.04 a share for the quarter ended Mar. 28, 2015. In the previous year period, the company reported a loss of $1.66 million, or $0.09 a share.

Advent Software, Inc. (NASDAQ:ADVS) has 0.80% insider ownership while its institutional ownership stands at 84.40%. In last trading activity company’s stock closed at $43.62. Advent Software Inc. (NASDAQ:ADVS) on May 07, reported first-quarter profit of $5 million. The San Francisco-based company said it had profit of 9 cents per share. Earnings, adjusted for one-time gains and costs, came to 34 cents per share.

Leave a Reply

Your email address will not be published. Required fields are marked *